InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Norwalk Leslie V, Director. Director active across 8 companies, notably Neurocrine Biosciences INC. In total, 30 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.7m. History available since 1 June 2021. The latest transaction was disclosed on 28 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Norwalk Leslie V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
1,250 shares@ US$182.006Common StockSEC:0001533568-26-000012:0
842 shares@ US$139.43Common StockSEC:0001533568-26-000012:1
15,527 sharesCommon StockSEC:0001628280-26-045787:0
1,447 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000070:0
3,810 shares@ US$155.01340.0035% mcap50.0% of flowCommon StockSEC:0001533568-26-000003:0
2,000 shares@ US$101.1016.6% of flowClass A Common StockSEC:0001193125-26-010697:0
8,276 shares@ US$92.3536.6% of flowCommon StockSEC:0001533568-25-000007:0
4,000 shares@ US$88.8534.7% of flowClass A Common StockSEC:0001193125-25-320898:0
1,652 shares@ US$76.0423.6% of flowCommon StockSEC:0000064803-25-000064:0
16,025 shares0Common StockSEC:0001655759-25-000112:0
1,435 shares0Common StockSEC:0000914475-25-000126:0
2,077 shares@ US$60.4723.8% of flowCommon StockSEC:0001127602-25-014957:0
2,200 shares@ US$57.1025.2% of flowCommon StockSEC:0001127602-24-028008:0
1,000 shares@ US$70.0011.3% of flowClass A Common StockSEC:0000950170-24-083594:0
5,899 shares0Common StockSEC:0001655759-24-000081:0
2,100 shares0Common StockSEC:0000914475-24-000132:0
10,590 shares@ US$51.9988.7% of flowClass A Common StockSEC:0000950170-24-033817:0
8,000 shares@ US$84.9538.4% of flowCommon StockSEC:0000914475-24-000080:0
2,658 shares0Common StockSEC:0001437749-24-004597:0
2,321 sharesClass A Common StockSEC:0001209191-23-048414:0
3,095 sharesCommon Stock, par value $0.001 per shareSEC:0001209191-23-048186:0
4,121 shares0Common StockSEC:0001655759-23-000066:0
1,314 shares0Common StockSEC:0001437749-23-003976:0
1,547 shares0Common StockSEC:0001209191-22-033199:0
381.005 shares@ US$82.020.0001% mcap100.0% of flowCommon StockSEC:0001071739-22-000147:0
25 of 30 declarations
About Norwalk Leslie V
Norwalk Leslie V is a Director with 28 filings in total. Across the 28 recent filings available, the recorded sell volume is EUR 1549432, with a date range from 2021-06-03 to 2026-06-26, and the top filings involve Neurocrine Biosciences INC and Globus Medical INC.
